HairDX unveils new genetic test for baldness
Monday, November 17th, 2008Pharmacogenomics research and development company PharmaGenoma Inc. and its subsidiary, HairDX LLC unveiled the next generation of genetic screening test for male pattern baldness. The test will be available immediately through qualified physicians.
By using the HairDX, a physician tests for the high-risk genetic variant that indicates a man has approximately a 70 percent chance of going bald. Conversely, the test can also identify those men who test negative that have approximately a 70 percent chance of not going bald.